Gijsen, Violette <br/><br/>
Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients.  [electronic resource] 

 -  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation  Dec 2011 
 - 1352-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3117 
<br/><br/><label>Standard No.: </label>10.1016/j.healun.2011.08.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Aging--immunology<br/>Child<br/>Cytochrome P-450 CYP3A--genetics<br/>Dose-Response Relationship, Drug<br/>Female<br/>Genotype<br/>Glomerular Filtration Rate--physiology<br/>Graft Rejection--immunology<br/>Heart Transplantation--immunology<br/>Humans<br/>Immunosuppressive Agents--pharmacokinetics<br/>Kidney--physiology<br/>Male<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Tacrolimus--pharmacokinetics<br/>Time Factors<br/>Treatment Outcome